Welcome to our dedicated page for Trimas SEC filings (Ticker: TRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TriMas Corporation filings document financial results, governance matters and material events for a Nasdaq-listed manufacturer serving packaging, life sciences and industrial markets. Form 8-K reports provide earnings releases, capital-structure updates, share repurchase activity, portfolio actions including the completed TriMas Aerospace divestiture, and executive or director changes.
Proxy materials describe annual meeting proposals, director elections, auditor ratification, executive compensation votes and board oversight. The filing record also covers material agreements, operating and financial results, and compensation arrangements tied to corporate governance.
TriMas (TRS) reported stronger Q3 2025 results, with net sales of $269.3 million, up from $229.4 million a year ago. Net income rose to $9.3 million ($0.23 diluted EPS) versus $2.5 million ($0.06) as operating profit improved and interest expense declined. For the nine months, sales reached $785.7 million and net income was $38.4 million ($0.94 diluted EPS).
Aerospace led growth, with Q3 sales of $103.2 million vs. $70.8 million, aided by the GMT Aerospace acquisition for $37.7 million. The Company also completed the sale of its Arrow Engine business for $21.0 million, recording a $5.4 million gain year‑to‑date.
Cash generation and balance sheet: net cash from operating activities was $75.9 million year‑to‑date; capital expenditures were $43.7 million. Long‑term debt was $407.1 million, including $400.0 million of 4.125% Senior Notes due 2029. The revolving credit facility was amended to $250.0 million maturing on 3/31/2030, with $10.9 million outstanding and $233.1 million available at quarter‑end.
The Company recorded an $8.0 million asbestos remeasurement, increasing the asbestos liability to $36.6 million, and began transitioning certain asbestos costs to excess insurance coverage. Shares outstanding were 40,642,475 as of September 30, 2025.
TriMas Corporation furnished a Form 8-K under Item 2.02 announcing it issued a press release on October 28, 2025 reporting financial results for the quarter ended September 30, 2025. The release is attached as Exhibit 99.1 and is available at www.trimas.com. The company states the information in Exhibit 99.1 is being furnished, not filed, and therefore is not subject to Section 18 of the Exchange Act or incorporated by reference into other filings.
Allspring Global Investments Holdings, LLC filed an amendment to Schedule 13G reporting beneficial ownership of 2,488,390 shares of TriMas Corp common stock, representing 6.1% of the class. The filing states Allspring has sole voting power over 2,407,857 shares and sole dispositive power over 2,488,390 shares. The shares are owned of record by clients of Allspring advisers and are held in the ordinary course of business; no client is identified as holding more than 5% of the class. The filing includes a subsidiary list naming Allspring Global Investments, LLC and Allspring Funds Management, LLC.
Trimas Corporation director Daniel P. Tredwell filed a Form 4 reporting a transaction dated 08/11/2025. The filing shows a transaction with code P, a reported price of $35.387, and a reported beneficial ownership following the transaction of 60,409.424 shares. The Form 4 also discloses 7,500 shares held indirectly by his spouse. The form was signed by an attorney-in-fact on 08/13/2025.
Trimas Corporation (TRS) filed a Form 144 reporting a proposed sale of 25,000 common shares through Wells Fargo Clearing Services with an aggregate market value of $919,012.13. The filing lists the securities exchange as Nasdaq and gives an approximate sale date of 08/13/2025.
The filing details the acquisition of the securities to be sold: 5,000 shares purchased on 10/28/2022, 10,000 shares on 03/01/2024 and 10,000 shares on 11/15/2024, with payment in cash. It also discloses recent open-market sales by Thomas A. Amato: 63,965 shares sold on 07/29/2025 for $2,241,703.40 and 13,900 shares sold on 07/31/2025 for $489,988.50. Outstanding common shares are listed as 40,641,562.
Bank of America Corporation reported beneficial ownership of 3,763,259 shares of TriMas Corporation common stock, representing 9.2% of the outstanding class on a Schedule 13G/A. The filing shows no sole voting or dispositive power and material shared voting (3,431,042) and shared dispositive (3,431,719) powers, reflecting holdings held through several wholly owned subsidiaries. The statement certifies these securities are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing identifies the specific BofA entities holding the positions.
Form 144 filed for TriMas Corporation (TRS) discloses that insider Thomas A. Amato plans to sell 36,705 common shares through Fidelity Brokerage on or about 31 Jul 2025 on Nasdaq. Based on the filing’s stated 40,641,562 shares outstanding, the proposed sale represents roughly 0.09 % of shares outstanding and carries an aggregate market value of ≈ $1.30 million.
The notice also lists recent insider activity: Amato sold 63,965 shares on 29 Jul 2025 for $2.24 million and 95,469 shares on 30 Jul 2025 for $3.39 million, totaling 159,434 shares (≈ 0.39 % of O/S) and ≈ $5.63 million in gross proceeds over the prior three months. All shares being sold were acquired via restricted-stock vesting between 2020-2024 and are treated as compensation, implying no cash outlay by the filer.
No adverse information about the issuer is asserted, and the filer affirms compliance with Rule 10b5-1/Rule 144 representations. While the volume is modest versus the float, consecutive sizeable sales within days could be viewed by investors as a potential negative sentiment signal from senior leadership.